Wave Life Sciences Ltd

(NASDAQ:WVE)

Latest On Wave Life Sciences Ltd (WVE):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsWave Life Sciences crashes on decision to drop neurology asset on trial setbackN/A
2023-05-03 17:10 ESTNewsWave Life Sciences GAAP EPS of -$0.27 misses by $0.23, revenue of $12.93M misses by $25.67MN/A
2023-05-03 17:10 ESTNewsWave Life Sciences Ltd. (WVE) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 16:03 ESTNewsWave Life Sciences Q1 2023 Earnings PreviewN/A
2023-03-22 19:19 ESTNewsWave Life Sciences GAAP EPS of -$0.47 misses by $0.06, revenue of $1.24M misses by $1.16MN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd (WVE) Q4 2022 Earnings Call TranscriptN/A
2023-03-21 11:59 ESTNewsWave Life Sciences Q4 2022 Earnings PreviewN/A
2023-03-13 05:38 ESTNewsRAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley BankN/A
2023-01-08 08:22 ESTNewsWave Life Sciences: Huntington's Hypotheses, GSK Collaboration Catalysts To Move The NeedleN/A
2022-12-13 14:27 ESTNewsWave Life stock surges 20% in team up with GSK for genetic diseasesN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. (WVE) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 07:50 ESTNewsWave Life Sciences GAAP EPS of -$0.42 beats by $0.08, revenue of $0.29M misses by $5.11MN/A
2022-11-09 14:49 ESTNewsWave Life Sciences Q3 2022 Earnings PreviewN/A
2022-09-21 00:13 ESTNewsWave Life's WVE-003 shows promise in interim data of Huntington's disease trialN/A
2022-08-11 17:59 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.08, revenue of $0.37MN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 01:42 ESTNewsWave Life Sciences Q2 2022 Earnings PreviewN/A
2022-06-22 10:01 ESTNewsRa Capital Management raises passive stake in Wave Life SciencesN/A
2022-06-15 00:46 ESTNewsWave Life Sciences to raise $70M in stock offeringN/A
2022-05-14 05:36 ESTNewsWave Life Sciences Ltd.'s (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-14 05:36 ESTNewsWave Life Sciences slips as H.C. Wainwright lowers targetN/A
2022-05-13 02:49 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.06, revenue of $1.75M misses by $2.11MN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-12 06:46 ESTNewsWave Life Sciences Q1 2022 Earnings PreviewN/A
2022-04-05 01:08 ESTNewsWave Life gains most in more than a year after early-stage data for ALS drugN/A
2022-03-31 02:14 ESTNewsWave Life Sciences (WVE) Investor Presentation - SlideshowN/A
2022-03-05 07:12 ESTNewsWave Life Sciences Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-03 20:07 ESTNewsWave Life Sciences GAAP EPS of -$0.61 misses by $0.06, revenue of $1.76M misses by $11.98MN/A
2022-03-03 20:06 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 02:56 ESTNewsWave Life Sciences Q4 2021 Earnings PreviewN/A
2022-01-25 21:00 ESTNewsWave Life Sciences' FTD, ALS clinical program to get investment from 2 organizationsN/A
2021-11-10 18:38 ESTNewsWave Life Sciences EPS beats by $0.52, beats on revenueN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-09 19:57 ESTNewsWave Life Sciences Q3 2021 Earnings PreviewN/A
2021-10-18 23:49 ESTNewsWave Life Sciences, Takeda amend CNS research collaborationN/A
2021-10-18 23:49 ESTNewsTakeda discontinues research with Wave for certain CNS programs; Wave to get $22.5MN/A
2021-09-30 02:27 ESTNewsDosing underway in Wave Life's mid-stage WVE-N531 study in Duchenne muscular dystrophyN/A
2021-09-29 03:19 ESTNewsWave Life Sciences falls after presentation on its RNA editing capability (Updated)N/A
2021-09-09 14:39 ESTNewsWave Life Sciences gets dosing underway in early-stage Huntington’s disease trialN/A
2021-08-17 03:33 ESTNewsWave Life Sciences Ltd. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-08 22:24 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-05 16:13 ESTNewsWave Life Sciences EPS misses by $0.14, misses on revenueN/A
2021-07-22 09:27 ESTNewsWave Life Sciences posts proof-of-concept data from genetic disorder studyN/A
2021-07-22 08:54 ESTNewsDosing underway in Wave Life Sciences' mid-stage WVE-004 study in neurodegenerative diseasesN/A
2021-03-29 20:19 ESTNewsWave Life Sciences falls on setback for Huntington’s disease trial (updated)N/A

About Wave Life Sciences Ltd (WVE):

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It develops WVE-120101 and WVE-120102, a stereopure therapeutic candidates, which are in Phase 1b/2a clinical trials for the treatment of Huntington's disease (HD); WVE-003, mutant huntingtin SNP3 program for the treatment of HD; WVE-004, C9orf72 program for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-N531, our Exon 53 program for the treatment of Duchenne muscular dystrophy; and ATXN3 program in SCA3. The company has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, and University of Massachusetts. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

See Advanced Chart

General

  • Name Wave Life Sciences Ltd
  • Symbol WVE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 217
  • Fiscal Year EndDecember
  • IPO Date2015-11-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.wavelifesciences.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 17.92
  • Price/Book (Most Recent Quarter) 5.85
  • Enterprise Value Revenue 16.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.80
  • Next Year EPS Estimate -$2.16
  • Next Quarter EPS Estimate -$0.53
  • Operating Margin -764%
  • Return on Assets -34%
  • Return on Equity -185%
  • Revenue 20.08 million
  • Earnings Per Share -$5.15
  • Revenue Per Share $0.51
  • Gross Profit -110867000
  • Quarterly Earnings Growth 293.3%
View More

Highlights

  • Market Capitalization 486.05 million
  • EBITDA -173971008
  • PE Ratio -9.74
  • Analyst Target Price $16.86
  • Book Value Per Share $1.70
View More

Share Statistics

  • Shares Outstanding 49 million
  • Shares Float 31.16 million
  • % Held by Insiders 1297%
  • % Held by Institutions 76.71%
  • Shares Short 4.92 million
  • Shares Short Prior Month 4.38 million
  • Short Ratio 9.71
  • Short % of Float 13%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 0.37
  • 52 Week High $19.98
  • 52 Week Low $6.76
  • 50 Day Moving Average 10.18
  • 200 Day Moving Average 9.71
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Wave Life Sciences Ltd (WVE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Wave Life Sciences Ltd (WVE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$9.44 million-$0.59-$0.602.14%
2020-09-302020-11-09$N/A-$0.86-$0.73-17.81%
2020-06-302020-08-10$N/A-$1.15-$1.07-7.48%
2020-03-312020-05-11$4.16 million-$1.38-$1.32-4.41%
2019-12-312020-03-02$2.4 million-$1.65-$1.46-13.35%
2019-09-302019-11-05$2.93 million-$1.48-$1.37-8.37%
2019-06-302019-07-29$7.63 million-$1.22-$1.00-22.31%
2019-03-312019-05-10$3.03 million-$1.36-$1.20-13.1%
2018-12-312019-03-01$3.62 million-$1.28-$1.25-2.81%
2018-09-302018-11-09$4.49 million-$1.28-$1.24-2.89%
2018-06-302018-08-09$4.88 million-$1.23-$1.10-11.56%
2018-03-312018-05-09$1.42 million-$1.26-$0.91-38.97%
2017-12-312018-03-12$1.68 million-$1.10-$1.04-5.43%
2017-09-302017-11-09$1.32 million-$0.94-$0.984.08%
2017-06-302017-08-09$1.1 million-$0.92-$0.81-13.23%
2017-03-312017-05-10$383000-$0.89-$0.76-17.49%
2016-12-312017-03-16$676000-$0.81-$0.67-20.45%
2016-09-302016-11-09$392000-$0.75-$0.53-41.51%
2016-06-302016-08-15$417000-$0.51-$0.37-37.84%
2016-03-312016-05-16$N/A-$0.36-$0.396.9%
2015-12-312016-03-30$N/A-$0.47-$0.32-46.88%
2015-09-302015-11-11$26000-$0.54-$0.29-86.21%

Wave Life Sciences Ltd (WVE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Wave Life Sciences Ltd (WVE) Chart:

Wave Life Sciences Ltd (WVE) News:

Below you will find a list of latest news for Wave Life Sciences Ltd (WVE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Wave Life Sciences Ltd (WVE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-1530CALL0 0340.69TRUE00
2026-05-1540CALL0 70TRUE00
2026-05-1552.1CALL0 880TRUE00
2026-05-1561.55CALL0 526117.69TRUE00
2026-05-1570.76CALL26 167971.52TRUE-0.14-0.16
2026-05-1580.35CALL8 77972.75FALSE-0.05-0.13
2026-05-1590.15CALL3 4274.58FALSE-0.05-0.25
2026-05-15100.07CALL0 2380FALSE00
2026-05-15110CALL0 5121.03FALSE00
2026-05-15120.05CALL0 6170.1FALSE00
2026-05-15130.05CALL0 203125.03FALSE00
2026-05-15140CALL0 342200.33FALSE00
2026-05-15150CALL0 271136.96FALSE00
2026-05-15160CALL0 0224.9FALSE00
2026-05-15170CALL0 2235.66FALSE00
2026-05-15180CALL0 0245.59FALSE00
2026-05-15190CALL0 0254.82FALSE00
2026-05-15200CALL0 1230.28FALSE00
2026-05-15210CALL0 0271.51FALSE00
2026-05-1530PUT0 0325.12FALSE00
2026-05-1540PUT0 0238.33FALSE00
2026-05-1550PUT0 152144.35FALSE00
2026-05-1560.13PUT0 1034169.05FALSE00
2026-05-1570.35PUT2 24462.39FALSE0.030.09
2026-05-1581.13PUT0 8765.03TRUE00
2026-05-1590PUT0 1520TRUE00
2026-05-15100PUT0 290TRUE00
2026-05-15110PUT0 290TRUE00
2026-05-15124.7PUT0 10TRUE00
2026-05-15130PUT0 00TRUE00
2026-05-15140PUT0 00TRUE00
2026-05-15150PUT0 00TRUE00
2026-05-15160PUT0 00TRUE00
2026-05-15170PUT0 00TRUE00
2026-05-15180PUT0 00TRUE00
2026-05-15190PUT0 00TRUE00
2026-05-15200PUT0 00TRUE00
2026-05-15210PUT0 00TRUE00
2026-06-1810CALL0 0477.36TRUE00
2026-06-1820CALL0 0282.04TRUE00
2026-06-1830CALL0 0193.49TRUE00
2026-06-1840CALL0 0139.72TRUE00
2026-06-1850CALL0 0120.57TRUE00
2026-06-1860CALL0 0163.89TRUE00
2026-06-1871.1CALL30 076.95TRUE1.10
2026-06-1880CALL0 098.69FALSE00
2026-06-1890CALL0 075.58FALSE00
2026-06-18100CALL0 0269.57FALSE00
2026-06-18110CALL0 0105.23FALSE00
2026-06-18120CALL0 0293.19FALSE00
2026-06-18130CALL0 0139.51FALSE00
2026-06-18140CALL0 0141.29FALSE00
2026-06-18150CALL0 0326.52FALSE00
2026-06-1810PUT0 00FALSE00
2026-06-1820PUT0 00FALSE00
2026-06-1830PUT0 0710.49FALSE00
2026-06-1840PUT0 0199.96FALSE00
2026-06-1850PUT0 0214.92FALSE00
2026-06-1860PUT0 070.43FALSE00
2026-06-1870PUT0 069.27FALSE00
2026-06-1880PUT0 0122.66TRUE00
2026-06-1890PUT0 0118.39TRUE00
2026-06-18100PUT0 055.36TRUE00
2026-06-18113.52PUT2 0152.11TRUE3.520
2026-06-18120PUT0 078.15TRUE00
2026-06-18130PUT0 080.39TRUE00
2026-06-18140PUT0 00TRUE00
2026-06-18150PUT0 00TRUE00
2026-07-1710CALL0 0368.96TRUE00
2026-07-1720CALL0 30246.39TRUE00
2026-07-1730CALL0 0174.33TRUE00
2026-07-1740CALL0 0133.88TRUE00
2026-07-1752.7CALL1 12795.63TRUE-0.04-0.01
2026-07-1762CALL7 21390.51TRUE20
2026-07-1771.3CALL500 24977.34TRUE-0.35-0.21
2026-07-1780.89CALL105 93477.02FALSE-0.11-0.11
2026-07-1790.54CALL2 33372.52FALSE-0.12-0.18
2026-07-17100.45CALL0 35884.65FALSE00
2026-07-17110.3CALL502 21179.98FALSE0.060.25
2026-07-17120CALL0 7492.42FALSE00
2026-07-17130CALL0 18887.9FALSE00
2026-07-17140CALL0 329111.79FALSE00
2026-07-17150.15CALL0 706119.03FALSE00
2026-07-17160CALL0 97125.62FALSE00
2026-07-17170CALL0 20131.68FALSE00
2026-07-17180CALL0 85137.27FALSE00
2026-07-17190CALL0 90142.46FALSE00
2026-07-17200CALL0 157116.67FALSE00
2026-07-17210CALL0 20151.85FALSE00
2026-07-17220CALL0 0156.12FALSE00
2026-07-17230CALL0 4160.15FALSE00
2026-07-17240CALL0 9163.96FALSE00
2026-07-17250CALL0 334167.58FALSE00
2026-07-17260CALL0 238171.02FALSE00
2026-07-17270CALL0 1174.3FALSE00
2026-07-17280CALL0 17177.44FALSE00
2026-07-17290CALL0 2180.43FALSE00
2026-07-17300CALL0 13183.31FALSE00
2026-07-17310CALL0 11186.07FALSE00
2026-07-17320CALL0 191188.72FALSE00
2026-07-17330CALL0 9191.27FALSE00
2026-07-17340CALL0 1193.74FALSE00
2026-07-17350CALL0 127196.11FALSE00
2026-07-1710PUT0 0254.55FALSE00
2026-07-1720PUT0 11187.46FALSE00
2026-07-1730PUT0 0126.26FALSE00
2026-07-1740.34PUT0 590.83FALSE00
2026-07-1750.39PUT0 19081.92FALSE00
2026-07-1760PUT0 12677.24FALSE00
2026-07-1770.85PUT5 12772.32FALSE0.850
2026-07-1780PUT0 18073.32TRUE00
2026-07-1790PUT0 2263.08TRUE00
2026-07-17100PUT0 11154.47TRUE00
2026-07-17110PUT0 1370TRUE00
2026-07-17120PUT0 1410TRUE00
2026-07-17130PUT0 540TRUE00
2026-07-17140PUT0 150TRUE00
2026-07-17150PUT0 1980TRUE00
2026-07-17160PUT0 30TRUE00
2026-07-17170PUT0 00TRUE00
2026-07-17180PUT0 00TRUE00
2026-07-17190PUT0 00TRUE00
2026-07-17200PUT0 00TRUE00
2026-07-17210PUT0 00TRUE00
2026-07-17220PUT0 00TRUE00
2026-07-17230PUT0 00TRUE00
2026-07-17240PUT0 00TRUE00
2026-07-17250PUT0 00TRUE00
2026-07-17260PUT0 00TRUE00
2026-07-17270PUT0 00TRUE00
2026-07-17280PUT0 00TRUE00
2026-07-17290PUT0 00TRUE00
2026-07-17300PUT0 00TRUE00
2026-07-17310PUT0 00TRUE00
2026-07-17320PUT0 00TRUE00
2026-07-17330PUT0 00TRUE00
2026-07-17340PUT0 00TRUE00
2026-07-17350PUT0 00TRUE00
2026-10-1630CALL0 5141.36TRUE00
2026-10-1640CALL0 0112.53TRUE00
2026-10-1650CALL0 0105.83TRUE00
2026-10-1662.31CALL3 2781.08TRUE2.310
2026-10-1671.8CALL35 1679.14TRUE1.80
2026-10-1681.51CALL4 183.52FALSE1.510
2026-10-1690CALL0 092.6FALSE00
2026-10-16100.93CALL0 26100.56FALSE00
2026-10-16110CALL0 095.51FALSE00
2026-10-16120.6CALL0 6278.57FALSE00
2026-10-16130CALL0 4376.15FALSE00
2026-10-16140CALL0 486.78FALSE00
2026-10-16150.34CALL0 1387.19FALSE00
2026-10-16160CALL0 0189.81FALSE00
2026-10-16170CALL0 5194.73FALSE00
2026-10-16180CALL0 2196.84FALSE00
2026-10-16190CALL0 0201.06FALSE00
2026-10-16200CALL0 6162.21FALSE00
2026-10-16210CALL0 1117.95FALSE00
2026-10-16250.15CALL2 6198.47FALSE0.150
2026-10-1630PUT0 090.28FALSE00
2026-10-1640PUT0 082.53FALSE00
2026-10-1650PUT0 280.17FALSE00
2026-10-1660.94PUT3 1684.34FALSE0.940
2026-10-1671.23PUT0 574.63FALSE00
2026-10-1680PUT0 080.6TRUE00
2026-10-1692.71PUT0 374.94TRUE00
2026-10-16100PUT0 1166.54TRUE00
2026-10-16110PUT0 266.14TRUE00
2026-10-16125.3PUT0 3367.53TRUE00
2026-10-16130PUT0 261.59TRUE00
2026-10-16140PUT0 00TRUE00
2026-10-16150PUT0 00TRUE00
2026-10-16160PUT0 00TRUE00
2026-10-16170PUT0 074.68TRUE00
2026-10-16180PUT0 00TRUE00
2026-10-16190PUT0 20TRUE00
2026-10-16200PUT0 00TRUE00
2026-10-16210PUT0 00TRUE00
2026-10-16250PUT0 00TRUE00
2026-12-1830CALL0 3595.5TRUE00
2026-12-1840CALL0 0104.02TRUE00
2026-12-1853.2CALL0 16098.05TRUE00
2026-12-1860CALL0 287.94TRUE00
2026-12-1872.09CALL15 4880.6TRUE2.090
2026-12-1881.81CALL0 2288.02FALSE00
2026-12-1890CALL0 086.55FALSE00
2026-12-18100CALL0 49185.1FALSE00
2026-12-18110CALL0 3133.33FALSE00
2026-12-18120CALL0 17282.37FALSE00
2026-12-18130CALL0 082.8FALSE00
2026-12-18140CALL0 4128.43FALSE00
2026-12-18150.72CALL0 68383.05FALSE00
2026-12-18160CALL0 084.62FALSE00
2026-12-18170CALL0 8581.15FALSE00
2026-12-18180CALL0 54178.78FALSE00
2026-12-18200CALL0 21693.99FALSE00
2026-12-18220CALL0 6194.59FALSE00
2026-12-18250.15CALL0 133150.15FALSE00
2026-12-18270CALL0 2185.83FALSE00
2026-12-18300CALL0 95177.29FALSE00
2026-12-18320CALL0 2210.44FALSE00
2026-12-18350CALL0 218135.55FALSE00
2026-12-1830PUT0 078.31FALSE00
2026-12-1840PUT0 074.28FALSE00
2026-12-1850PUT0 5273.15FALSE00
2026-12-1861.1PUT1 181.85FALSE1.10
2026-12-1870PUT0 11473.18FALSE00
2026-12-1880PUT0 077TRUE00
2026-12-1890PUT0 081.66TRUE00
2026-12-18103.4PUT0 6572.2TRUE00
2026-12-18110PUT0 270.94TRUE00
2026-12-18120PUT0 1468.59TRUE00
2026-12-18130PUT0 263.29TRUE00
2026-12-18140PUT0 060.83TRUE00
2026-12-18150PUT0 570TRUE00
2026-12-18160PUT0 10TRUE00
2026-12-18170PUT0 00TRUE00
2026-12-18180PUT0 378.08TRUE00
2026-12-18200PUT0 100TRUE00
2026-12-18220PUT0 20TRUE00
2026-12-18250PUT0 50TRUE00
2026-12-18270PUT0 10TRUE00
2026-12-18300PUT0 00TRUE00
2026-12-18320PUT0 00TRUE00
2026-12-18350PUT0 00TRUE00
2027-01-1534.8CALL0 3396.13TRUE00
2027-01-1540CALL0 0105.75TRUE00
2027-01-1550CALL0 26093.95TRUE00
2027-01-1560CALL0 095.38TRUE00
2027-01-1570CALL0 096.34TRUE00
2027-01-1580CALL0 1288.25FALSE00
2027-01-1590CALL0 088.71FALSE00
2027-01-15101.4CALL2 42284.35FALSE1.40
2027-01-15121.05CALL0 1276.78FALSE00
2027-01-15150.64CALL0 285.67FALSE00
2027-01-15170CALL0 3103.84FALSE00
2027-01-15200.25CALL0 83110.47FALSE00
2027-01-15220CALL0 291.07FALSE00
2027-01-1530PUT0 086.28FALSE00
2027-01-1540.4PUT6 083.99FALSE0.40
2027-01-1550PUT0 983.46FALSE00
2027-01-1560PUT0 077.91FALSE00
2027-01-1570PUT0 080.56FALSE00
2027-01-1580PUT0 7075.45TRUE00
2027-01-1590PUT0 084.89TRUE00
2027-01-15100PUT0 071.06TRUE00
2027-01-15120PUT0 075.11TRUE00
2027-01-15150PUT0 063.3TRUE00
2027-01-15170PUT0 00TRUE00
2027-01-15200PUT0 00TRUE00
2027-01-15220PUT0 00TRUE00
2027-06-1730CALL0 0105.58TRUE00
2027-06-1750CALL0 250131.61TRUE00
2027-06-1780CALL0 64100.43FALSE00
2027-06-17100CALL0 0106.06FALSE00
2027-06-17120CALL0 0119.37FALSE00
2027-06-17151.2CALL1 985.06FALSE1.20
2027-06-17170CALL0 0132.56FALSE00
2027-06-17200CALL0 0140.92FALSE00
2027-06-17220CALL0 086.54FALSE00
2027-06-1730PUT0 0307.42FALSE00
2027-06-1750PUT0 1155.15FALSE00
2027-06-1782.74PUT0 581.58TRUE00
2027-06-17100PUT0 073.92TRUE00
2027-06-17120PUT0 073.54TRUE00
2027-06-17150PUT0 067.98TRUE00
2027-06-17170PUT0 068.31TRUE00
2027-06-17200PUT0 066.15TRUE00
2027-06-17220PUT0 076.53TRUE00
2028-01-2135.7CALL0 107103.71TRUE00
2028-01-2150CALL0 2081.52TRUE00
2028-01-2184.15CALL0 13104.96FALSE00
2028-01-21102.7CALL5 2287.14FALSE2.70
2028-01-21120CALL0 096.03FALSE00
2028-01-21150CALL0 098.73FALSE00
2028-01-21170CALL0 0108.21FALSE00
2028-01-21200CALL0 4113.75FALSE00
2028-01-21220CALL0 2117.6FALSE00
2028-01-2130PUT0 2256.77FALSE00
2028-01-2150PUT0 4665.96FALSE00
2028-01-2180PUT0 280.2TRUE00
2028-01-21100PUT0 076.19TRUE00
2028-01-21120PUT0 075.17TRUE00
2028-01-21150PUT0 5073.29TRUE00
2028-01-21170PUT0 072.68TRUE00
2028-01-21200PUT0 074.49TRUE00
2028-01-21220PUT0 067.99TRUE00

Latest WVE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$2
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$1.995

Wave Life Sciences Ltd (WVE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2019-08-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019012261/0000000000-19-012261-index.htm
2019-11-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019015921/0000000000-19-015921-index.htm
2019-12-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019016177/0000000000-19-016177-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025519002715/0000080255-19-002715-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025520001311/0000080255-20-001311-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719006909/0000215457-19-006909-index.htm
2019-03-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719007594/0000215457-19-007594-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000083423720008192/0000834237-20-008192-index.htm
2020-08-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000089542120000470/0000895421-20-000470-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022514/0000899243-18-022514-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022515/0000899243-18-022515-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-11-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021292/0000899243-19-021292-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021959/0000899243-19-021959-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021962/0000899243-19-021962-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021963/0000899243-19-021963-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021965/0000899243-19-021965-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021966/0000899243-19-021966-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021967/0000899243-19-021967-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023028/0000899243-19-023028-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023032/0000899243-19-023032-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023033/0000899243-19-023033-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023034/0000899243-19-023034-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023035/0000899243-19-023035-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023038/0000899243-19-023038-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2020-01-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320001393/0000899243-20-001393-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007277/0000899243-20-007277-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007281/0000899243-20-007281-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007282/0000899243-20-007282-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007284/0000899243-20-007284-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007285/0000899243-20-007285-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023078/0000899243-20-023078-index.htm
2020-08-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023079/0000899243-20-023079-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023080/0000899243-20-023080-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023085/0000899243-20-023085-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023086/0000899243-20-023086-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023087/0000899243-20-023087-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023088/0000899243-20-023088-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023089/0000899243-20-023089-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023092/0000899243-20-023092-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023093/0000899243-20-023093-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000090221920000204/0000902219-20-000204-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000110465920021834/0001104659-20-021834-index.htm
2019-01-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003157/0001144204-19-003157-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419008078/0001144204-19-008078-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518270464/0001193125-18-270464-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518290300/0001193125-18-290300-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518291962/0001193125-18-291962-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518295345/0001193125-18-295345-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323137/0001193125-18-323137-index.htm
2018-11-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323760/0001193125-18-323760-index.htm
2018-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518342992/0001193125-18-342992-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519001144/0001193125-19-001144-index.htm
2019-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519014851/0001193125-19-014851-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519014884/0001193125-19-014884-index.htm
2019-01-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519015961/0001193125-19-015961-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519015976/0001193125-19-015976-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519040844/0001193125-19-040844-index.htm
2019-02-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519045277/0001193125-19-045277-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519059251/0001193125-19-059251-index.htm
2019-03-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519074933/0001193125-19-074933-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519107259/0001193125-19-107259-index.htm
2019-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000119312519125660/0001193125-19-125660-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519143674/0001193125-19-143674-index.htm
2019-05-10S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1631574/000119312519144278/0001193125-19-144278-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519165571/0001193125-19-165571-index.htm
2019-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519182697/0001193125-19-182697-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519205421/0001193125-19-205421-index.htm
2019-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1631574/000119312519214152/0001193125-19-214152-index.htm
2019-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519214169/0001193125-19-214169-index.htm
2019-08-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519218981/0001193125-19-218981-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519221246/0001193125-19-221246-index.htm
2019-08-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519223468/0001193125-19-223468-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519238229/0001193125-19-238229-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519263797/0001193125-19-263797-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284729/0001193125-19-284729-index.htm
2019-11-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284817/0001193125-19-284817-index.htm
2019-12-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519304738/0001193125-19-304738-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519314469/0001193125-19-314469-index.htm
2019-12-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519322733/0001193125-19-322733-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519325442/0001193125-19-325442-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005483/0001193125-20-005483-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005882/0001193125-20-005882-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520026760/0001193125-20-026760-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520037841/0001193125-20-037841-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520038291/0001193125-20-038291-index.htm
2020-03-02POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057766/0001193125-20-057766-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057791/0001193125-20-057791-index.htm
2020-03-02POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057905/0001193125-20-057905-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520107212/0001193125-20-107212-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520117339/0001193125-20-117339-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520138276/0001193125-20-138276-index.htm
2020-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520181069/0001193125-20-181069-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214106/0001193125-20-214106-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214144/0001193125-20-214144-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214223/0001193125-20-214223-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520223731/0001193125-20-223731-index.htm
2020-08-198-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520224764/0001193125-20-224764-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520229903/0001193125-20-229903-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520241608/0001193125-20-241608-index.htm
2020-09-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520251261/0001193125-20-251261-index.htm
2020-09-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520251297/0001193125-20-251297-index.htm
2020-09-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520252307/0001193125-20-252307-index.htm
2020-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520252347/0001193125-20-252347-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520254552/0001193125-20-254552-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520260543/0001193125-20-260543-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000113/0001274173-19-000113-index.htm
2019-08-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000120/0001274173-19-000120-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417320000004/0001274173-20-000004-index.htm
2020-01-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000149315220000835/0001493152-20-000835-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459018028757/0001564590-18-028757-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/0001564590-19-005671-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019018521/0001564590-19-018521-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019029396/0001564590-19-029396-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019040431/0001564590-19-040431-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/0001564590-20-007972-index.htm
2020-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020019772/0001564590-20-019772-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020023860/0001564590-20-023860-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020038620/0001564590-20-038620-index.htm
2019-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999519001883/9999999995-19-001883-index.htm
2020-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999520000974/9999999995-20-000974-index.htm
2018-09-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1631574/999999999718007937/9999999997-18-007937-index.htm

Wave Life Sciences Ltd (WVE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Wave Life Sciences Ltd (WVE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1297%
Institutional Ownership: 7671%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-19Keith RegnanteChief Financial OfficerSell1,298.0036.8447,817.8015,686.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2018-09-24Keith RegnanteChief Financial OfficerSell29,500.0055.001,622,500.0016,984.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-02-19Chris FrancisOfficerSell1,709.0036.8462,959.0520,368.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2018-09-24Chris FrancisOfficerSell1,032.0056.0057,792.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-25Chris FrancisOfficerSell10,543.0056.00590,408.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-24Chris FrancisOfficerBuy1,032.002.482,559.3623,109.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-02-19Chandra VargeeseSenior VP, Drug DiscoverySell2,055.0036.8475,706.2025,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell119.0037.474,458.45271,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell7,614.0036.38276,997.32271,328.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell43,068.0010.26441,877.68272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell95,921.0010.27985,108.67272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-25PAUL BOLNOPresident and CEOSell25,000.0012.00300,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-15PAUL BOLNOPresident and CEOSell100,000.0015.001,500,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoverySell3,000.0055.00165,000.0027,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2019-03-07Keith RegnanteChief Financial OfficerBuy13,500.0029,186.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2020-08-25PAUL BOLNOPresident and CEOBuy25,000.002.4862,000.00297,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2019-11-20Gregory L. VerdineDirectorSell2,609.0032.7485,418.6630,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoveryBuy3,000.002.487,440.0030,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2020-02-18Chris FrancisOfficerSell2,708.007.8521,257.8031,160.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,509.0010.8248,787.38315,249.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18PAUL BOLNOPresident and CEOSell11,451.007.8589,890.35319,758.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2019-11-20Gregory L. VerdineDirectorSell3,400.0031.59107,406.0032,609.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-25Chris FrancisOfficerBuy10,543.002.4826,146.6432,620.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-03-07PAUL BOLNOPresident and CEOBuy60,000.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell1,763.0046.0081,098.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell8,237.0045.22372,477.14332,972.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-07Chris FrancisOfficerBuy13,500.0033,868.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell5,065.0045.89232,432.85341,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell34,935.0045.451,587,795.75346,274.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy35,000.0035,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-11-20Gregory L. VerdineDirectorSell24,030.0030.27727,388.1036,009.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,079.0010.9144,501.89368,102.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18Chandra VargeeseSenior VP, Drug DiscoverySell3,188.007.8525,025.8037,057.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-07-02PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-09-15PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2019-02-19Michael A. PanzaraFranchise Lead, NeurologySell1,837.0036.8467,673.9837,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-03-15PAUL BOLNOPresident and CEOBuy50,000.002.48124,000.00381,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy4,000.0039,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2020-02-18Michael A. PanzaraChief Medical OfficerSell2,981.007.8523,400.8539,349.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2019-03-07Chandra VargeeseSenior VP, Drug DiscoveryBuy15,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoverySell6,000.0035.00210,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell445.0027.2612,130.7042,330.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell2,613.0026.8870,237.4442,775.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-03-11Michael A. PanzaraFranchise Lead, NeurologySell7,000.0048.00336,000.0045,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoveryBuy6,000.002.4814,880.0046,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2018-09-24Keith RegnanteChief Financial OfficerBuy29,500.0020.89616,255.0046,484.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-03-07Michael A. PanzaraFranchise Lead, NeurologyBuy15,000.0052,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2018-11-14Gregory L. VerdineDirectorSell4,300.0039.52169,936.0060,039.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2020-02-03David G GaieroInterim CFOSell651.007.004,557.006,392.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2018-11-14Gregory L. VerdineDirectorSell10,700.0038.59412,913.0064,339.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-01-24RA CAPITAL MANAGEMENT, LLCDirectorBuy263,158.0038.0010,000,004.007,775,207.00https://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm